Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after traumatic brain injury in rats (Q43698577)

26 November 2017

title

Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after traumatic brain injury in rats (English)

1 reference

26 November 2017

main subject

traumatic brain injury

0 references

author name string

Rao VL

1

1 reference

26 November 2017

Dogan A

2

1 reference

26 November 2017

Todd KG

3

1 reference

26 November 2017

Bowen KK

4

1 reference

26 November 2017

Dempsey RJ

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

911

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

96-100

1 reference

Memantine reduces functional and morphological consequences induced by global ischemia in rats.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Protective effects of moderate hypothermia on behavioral deficits but not necrotic cavitation following cortical impact injury in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Protective effects of memantine against ischemia-reperfusion injury in spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Clinical neuro-protection trials in severe traumatic brain injury: lessons from previous studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Memantine for prevention of spinal cord injury in a rabbit model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

[Pharmacotherapy of Alzheimer dementia: therapy of cognitive symptoms--new results of clinical studies]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Brain penetration and in vivo recovery of NMDA receptor antagonists amantadine and memantine: a quantitative microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Novel pharmacologic strategies in the treatment of experimental traumatic brain injury: 1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Excitatory amino acid receptor subtype binding following traumatic brain injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Clinical experience with excitatory amino acid antagonist drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Activation of metabotropic glutamate receptor subtype mGluR1 contributes to post-traumatic neuronal injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

The rationale for glutamate antagonists in the treatment of traumatic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Changes in cortical extracellular levels of energy-related metabolites and amino acids following concussive brain injury in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Memantine reduces alterations to the mammalian retina, in situ, induced by ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Traumatic injury to rat brain upregulates neuronal nitric oxide synthase expression and L-[3H]nitroarginine binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

[Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902617-8

10.1016/S0006-8993(01)02617-8

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference